Rossari Biotech Limited

NSEI:ROSSARI 株式レポート

時価総額:₹49.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Rossari Biotech 配当金

配当金 基準チェック /06

Rossari Biotech配当を支払う会社であり、現在の利回りは0.055%です。

主要情報

0.06%

配当利回り

2%

配当性向

業界平均利回り0.6%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金₹0.500
一株当たり利益₹24.66
配当利回り予想0.6%

最近の配当金アップデート

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

決済の安定と成長

配当データの取得

安定した配当: ROSSARIはIndian市場で注目すべき配当金を支払っていないため、支払いが安定しているかどうかを確認する必要はありません。

増加する配当: ROSSARIはIndian市場で注目すべき配当金を支払っていないため、支払額が増加しているかどうかを確認する必要はありません。


配当利回り対市場

Rossari Biotech 配当利回り対市場
ROSSARI 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (ROSSARI)0.06%
市場下位25% (IN)0.2%
市場トップ25% (IN)1.0%
業界平均 (Chemicals)0.6%
アナリスト予想 (ROSSARI) (最長3年)0.6%

注目すべき配当: ROSSARIの配当金 ( 0.066% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) と比べると目立ったものではありません。

高配当: ROSSARIの配当金 ( 0.065% ) はIndian市場の配当金支払者の上位 25% ( 1.12% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: ROSSARI Indian市場において目立った配当金を支払っていません。


株主配当金

キャッシュフローカバレッジ: ROSSARIは配当金を支払っていますが、同社にはフリーキャッシュフローがありません。


高配当企業の発掘